Pharma Advertising and Information (Basic)

Learn the Danish laws and rules on information for healthcare professionals (HCPs) and the public

17. Mar 2022
15. Sep 2022

1 day course

Danish

5,950 DKK ex VAT
(app. 800 EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

Special rules apply when informing healthcare professionals and the general public about pharmaceutical products: Most pharma information is considered advertising, a lot of advertising tools and methods are not allowed in pharma, and for pharma advertising to be legal, certain conditions have to be met.

This course is designed to help you understand which rules apply. You will be introduced to the legal requirements for different pharmaceutical products, audiences and media, so you can avoid common and costly pitfalls.

The purpose of the seminar is to enable you to keep your pharma information and promotional materials compliant.
 

Keywords

  • Pharmaceutical advertising
  • Medical information
  • Promotional materials
  • Compulsory information
  • HCPs, certain professions, general audience
  • Channels, media, formats
  • Push versus pull

Hi! Do you need help choosing the right course?

We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com

Stay tuned with Atrium's newsletter

Read more

IS THIS COURSE FOR YOU?

This course is relevant for you if you need to be familiar with the applicable rules for medical information or pharmaceutical promotional materials directed at healthcare professionals and the general public, in both digital and traditional media. 

This course is particularly relevant for you if you are working in compliance, marketing or communication. You will also find this course useful if you are a professional working in a communication or advertising agency or a firm providing consulting services to the pharmaceutical industry.

What you will learn

  1. How to distinguish between pharmaceutical information and advertising and know under which circumstances both, one or none of them are allowed
  2. Compulsory information and general requirements to pharmaceutical information for health care professionals and laypersons
  3. Compliance challenges with respect to the choice of channel and form, e.g. digital and traditional media
  4. What ENLI (The Ethical Committee for the Pharmaceutical Industry in Denmark) investigators look for when they scrutinize pharmaceutical information and ads

What your company will get

  1. An employee who can distinguish legal pharma information from illegal pharma promotion
  2. An employee who masters the requirements for promotional materials aimed at health care professionals
  3. An employee who is able to keep your communication with patients and the general public compliant
  4. An employee who knows what ENLI looks for in media and ads and who can keep your company stay compliant

Course calendar

Choose your starting date
Starting 17. Mar 2022
Starting 15. Sep 2022
17. Mar 2022 9:00-16:00

DAY 1

Defining advertising and information in a pharma context

Who is considered a health care professional? When is a specific communication instrument or action considered information or promotion? When is it legal to inform whom about what?

Pharma regulation

EU and Danish national legislation versus the ethical rules of EFPIA and the Danish self-regulatory body ENLI (The Danish Ethical Committee for the Pharma¬ceutical Industry). Who makes the rules and who has to comply? How are they monitored? How are violations sanctioned?

Compulsory information, specific professions, particular media

Compulsory information for HCPs versus the public. Advertising to professionals advising on medicinal products. Communicating with investors and the press. Using digital media: GDPR, permission marketing, email, website, social media, outdoor advertising, video, radio, TV, shop monitors.

General requirements when informing healthcare professionals and the public about pharma

Are discounts, money back guarantees or other incentives allowed? Can you deviate from the wordings of the summary of product characteristics (SPC) if your information is factual? When is pharma advertising “adequate” and “factual”? When is information considered misleading or exag¬gerating?

Workshop: How to scrutinize pharma information like an ENLI investigator

Hands-on learning from real cases. How to evaluate scientific references and to distinguish an insufficient from a wellsubstantiated claim. How to assess which graphs, photos and other visuals are helpful and which are misleading. How to determine whether a comparative ad is fair play or unfair competition.

Practical information

Registration

Registration deadline
16. Mar 2022
Atrium
Lersø Parkallé 101
2100 København Ø
Register
17 Mar
15. Sep 2022 9:00-16:00

DAY 1

Defining advertising and information in a pharma context

Who is considered a health care professional? When is a specific communication instrument or action considered information or promotion? When is it legal to inform whom about what?

Pharma regulation

EU and Danish national legislation versus the ethical rules of EFPIA and the Danish self-regulatory body ENLI (The Danish Ethical Committee for the Pharma¬ceutical Industry). Who makes the rules and who has to comply? How are they monitored? How are violations sanctioned?

Compulsory information, specific professions, particular media

Compulsory information for HCPs versus the public. Advertising to professionals advising on medicinal products. Communicating with investors and the press. Using digital media: GDPR, permission marketing, email, website, social media, outdoor advertising, video, radio, TV, shop monitors.

General requirements when informing healthcare professionals and the public about pharma

Are discounts, money back guarantees or other incentives allowed? Can you deviate from the wordings of the summary of product characteristics (SPC) if your information is factual? When is pharma advertising “adequate” and “factual”? When is information considered misleading or exag¬gerating?

Workshop: How to scrutinize pharma information like an ENLI investigator

Hands-on learning from real cases. How to evaluate scientific references and to distinguish an insufficient from a wellsubstantiated claim. How to assess which graphs, photos and other visuals are helpful and which are misleading. How to determine whether a comparative ad is fair play or unfair competition.

Practical information

Registration

Registration deadline
14. Sep 2022
Atrium
Lersø Parkallé 101
2100 København Ø
Register
15 Sep
Sometimes things change. This is the expected programme.

Course information

Literature

Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in. 

Please familiarize yourself with the mandatory readings before starting the course. The mandatory readings are also part of the examination syllabus.

Prior to starting the course, please familiarize yourself with The Pharmaceutical Industry’s Code of Practice on Promotion, etc., of Medicinal Products aimed at Health Care Professionals, especially §§1-11.

Please find both Danish and English versions at http://www.enli.dk/regler/reklamekodeks/ 

Examination

The exam is usually held 4-6 weeks after the course. You can take the exam in your own country.

Please let us know if this is relevant for you as we can conduct exams at embassies, universities and so on worldwide.

Exam is only relevant if you want to obtain a Marketing Compliance Diploma.

From now on you only need to complete the two compulsory courses (Pharma Interaction + Pharma Advertising) in order to take the exam. Please go to the Marketing Compliance Programme page to learn more.

This course is a part of this programme

Marketing Compliance Programme

Depending on your focus in the pharmaceutical industry you can tailor your compliance training to meet your needs. Flexibly choose from the six courses of the Marketing Compliance Programme and earn your diploma in marketing compliance

Read more

You may also be interested in these courses

WANT TO KNOW MORE or need help?

Contact Client Manager Ida Salicath at +45 39 15 09 46

Send me a message